EUVIMEDEUVIMED entdecken
Crossref

Stress granule assembly represents a therapeutic vulnerability in super-enhancer-driven circMLB-mediated glioblastoma temozolomide resistance

Ruixiang Huang, Zhihao Yang, Yongfei Dong, Mengxia Liang, Tao Chen, Han Xie, Jun Liu, Yanyi Jiang, Dasheng Tian, Erbao Bian

Cancer Letters · 2026

DOI: 10.1016/j.canlet.2026.218601 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2026. Verfasst von Ruixiang Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, 678 Fu Rong Road, Hefei, Anhui Province, 230601, China; Insti…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Alkylating, Brain Neoplasms, Drug Resistance, Neoplasm, Glioblastoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Anhui Provincial Department of Education, Anhui Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Resistance to temozolomide (TMZ) is a major driver of treatment failure and high mortality in patients with glioblastoma (GBM). However, the mechanisms underlying TMZ resistance, especially intrinsic resistance, remain incompletely elucidated. Through integrative multi-omics analyses, we identified a novel super-enhancer-driven circular RNA, circMLB, which is highly overexpressed in TMZ-R GBM. Both in vitro and in vivo studies robustly demonstrate that circMLB significantly enhances TMZ resistance in GBM. Mechanistically, the transcription factor PAF1 forms a protein complex with BRD4 that is enriched in the super-enhancer region, thereby upregulating circMLB expression. Furthermore, highly expressed circMLB directly binds to PKR, triggering stress granule assembly and ultimately reinforcing TMZ resistance in GBM. Importantly, we identified a novel PKR inhibitor, lurasidone, which synergizes with TMZ to exert potent anti-tumor activity against TMZ-R GBM in preclinical models. Our findings uncover a previously unrecognized SE-circMLB-PKR axis mediating intrinsic TMZ resistance and highlight the lurasidone-TMZ combination as a promising therapeutic strategy to surmount TMZ resistance in GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Agents, AlkylatingBrain NeoplasmsDrug Resistance, NeoplasmGlioblastomaStress GranulesTemozolomideRNA, CircularAnimalsHumansMiceBromodomain Containing ProteinsCell Cycle ProteinsCell Line, TumoreIF-2 KinaseGene Expression Regulation, NeoplasticNuclear ProteinsSuper EnhancersTranscription FactorsXenograft Model Antitumor AssaysLurasidone HydrochlorideMaleFemaleMiddle AgedMice, Inbred BALB CMice, Nude

Stichwörter der Autor:innen

CircMLBGlioblastomaStress granuleSuper-enhancerTemozolomide

Substanzen

Antineoplastic Agents, AlkylatingBRD4 protein, humanBromodomain Containing ProteinsCell Cycle ProteinseIF-2 KinaseNuclear ProteinsTemozolomideTranscription FactorsLurasidone HydrochlorideRNA, Circular

Autor:innen und Institutionen

  • Department of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, 678 Fu Rong Road, Hefei, Anhui Province, 230601, China; Institute of Orthopaedics, Research Center for Translational Medicine, The…
  • Department of Neurosurgery, The Second Affiliated Hospital of Anhui Medical University, 678 Fu Rong Road, Hefei, Anhui Province, 230601, China.
  • School of Pharmacy, Anhui Medical University, Hefei, 230032, China.
  • Department of Neurosurgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China.
  • Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China; Hefei Cancer Hospital…

Förderung

  • National Natural Science Foundation of China
  • Anhui Provincial Department of Education
  • Anhui Medical University

Zitieren

APA

Huang, R., Yang, Z., Dong, Y., Liang, M., Chen, T., Xie, H., Liu, J., Jiang, Y., Tian, D., & Bian, E. (2026). Stress granule assembly represents a therapeutic vulnerability in super-enhancer-driven circMLB-mediated glioblastoma temozolomide resistance. Cancer Letters. https://doi.org/10.1016/j.canlet.2026.218601

Vancouver

Huang R, Yang Z, Dong Y, Liang M, Chen T, Xie H, et al. Stress granule assembly represents a therapeutic vulnerability in super-enhancer-driven circMLB-mediated glioblastoma temozolomide resistance. Cancer Letters. 2026. doi:10.1016/j.canlet.2026.218601

BibTeX
@article{Huang2026,
  author = {Huang, Ruixiang and Yang, Zhihao and Dong, Yongfei and Liang, Mengxia and Chen, Tao and Xie, Han and Liu, Jun and Jiang, Yanyi and Tian, Dasheng and Bian, Erbao},
  title = {Stress granule assembly represents a therapeutic vulnerability in super-enhancer-driven circMLB-mediated glioblastoma temozolomide resistance},
  journal = {Cancer Letters},
  year = {2026},
  doi = {10.1016/j.canlet.2026.218601}
}
Kostenlos starten →